References: Summary of Revisions: Standards of Care in Diabetes2026
compounding pharmacies to meet individual needs
GLP-1 receptor agonists are a class of prescription medications that essentially function the same way as GLP-1 produced in the body
This is usually your primary care doctor or a specialist
Summary measures and synthesis of results The principal summary outcome was the relative risk (RR) of several GI adverse events in people with overweight or obesity receiving treatment with GLP-1 RA, including nausea, vomiting, diarrhea, constipation, abdominal distension, upper abdominal pain, abdominal pain, abdominal discomfort, gastroesophageal reflux disease, (GERD), eructation, flatulence, decreased appetite, cholelithiasis, gallstone-related, cholecystitis, acute cholecystitis, acute pancreatitis, viral gastroenteritis, hard feces, and infrequent bowel movements